News

What Happened? A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed ...
What Happened? Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 13.8% in the afternoon session after the ...
View the latest Bruker Corp. (BRKR) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...
Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.
Bruker Corporation is a life-sciences company that has delivered returns of 20% annually for the last 15 years, comfortably beating the S&P 500. However, the share price has fallen -34% from its ...
Bruker expects to right-size PhenomeX’s cost structure immediately and expects the acquisition of PhenomeX to be slightly dilutive to Bruker’s non-GAAP EPS in 2024 and 2025, and accretive to ...
Bruker announces the launch of the proteoElute, a state-of-the-art nanoflow liquid chromatography (LC) system designed for robust and ultra-sensitive multiomics applications. The proteoElute is ...
Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...
Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell ...
Bruker won the auction, held Tuesday, by increasing its earlier qualifying bid with a revised offer that was 78% above the $220 million offered by healthcare investment firm Patient Square Capital.
Bruker is down 40.2% since the beginning of the year, and at $35.16 per share, it is trading 50.2% below its 52-week high of $70.67 from September 2024. Investors who bought $1,000 worth of Bruker ...